Abstract
Cardiac K channels are critical determinants of cardiac excitability. In hypertrophied and failing myocardium, alterations in the expression and activity of voltage-gated K channels are frequently observed and contribute to the increased propensity for life-threatening arrhythmias. Thus, understanding the mechanisms of disturbed K channel regulation in heart failure (HF) is of critical importance. Amongst others, Ca/calmodulin-dependent protein kinase II (CaMKII) has been identified as an important regulator of K channel activity. In human HF but also various animal models, increased CaMKII expression and activity has been linked to deteriorated contractile function and arrhythmias. This review will discuss the current knowledge about CaMKII regulation of several K channels, its influence on action potential properties, dispersion of repolarization, and arrhythmias with special focus on HF.
INTRODUCTION
Heart failure (HF) is a leading cause of death in western countries (United States and Europe), (; ; ) but also in developing countries like China (). Morbidity in HF is characterized by contractile dysfunction and an increased propensity for arrhythmias (). Both are known consequences of the electro-mechanical remodeling of the cardiomyocyte. It is well established that reduced expression of K channels in hypertrophied and failing myocardium () can lead to action potential (AP) prolongation, which is known to be pro-arrhythmogenic. Moreover, AP prolongation also leads to greater systolic Ca entry through voltage-gated L-type Ca channels (CaV1.2) and impairs the Ca export function of cardiac Na/Ca exchange (NCX, ), which results in cytosolic Ca overload and dramatically impairs diastolic contractile function (Figure 1).
FIGURE 1
Thus, understanding the mechanisms that are involved in the regulation of cardiac K channel expression and function in HF could greatly improve patient treatment.
Ca/calmodulin-dependent protein kinase II (CaMKII) has been identified as an important regulator of ion channels and transporters involved in cardiac excitation–contraction coupling under physiological but also pathophysiological conditions (
K CHANNELS ARE IMPORTANT REGULATORS OF CARDIAC EXCITABILITY
The cardiac AP is initiated by activation of voltage-gated Na channels (NaV1.5). The resulting Na current (INa) leads to a rapid depolarization, i.e., the AP upstroke (phase 0;
In pacemaker cells, the absence of a stabilizing IK1 is responsible for a more positive resting membrane potential (
Several mechanisms of arrhythmogenesis involving K channels have been described. Reduced function of Kv7.1 and hERG are the hallmark of congential long QT syndrome 1 and 2, respectively (
Interestingly, besides rare congenital disease, altered K channel function has also been described for HF. It was shown that decreased IK1 and Ito density could lead to AP prolongation (
Increased triggered activity is an important consequence of prolonged repolarization. The longer phase 2 of the AP results in reactivation of Ca channels that generate a depolarizing current possibly resulting in an EAD and ultimately leading to a triggered AP (
Differential K channel expression across the ventricular wall is the basis for transmural dispersion of repolarization (TDR,
CaMKII AND HF
Calcium-Calmodulin-dependent kinase II is a serine/threonine kinase that can regulate multiple ion channels and transporters including K channels (see below). Currently, four isoforms and up to 30 splice-variants of the serine/threonine CaMKII have been identified, with CaMKIIδ as the predominant cardiac isoform (
CaMKII has been associated with HF development. In human HF, expression and activity of CaMKII is increased (
TRANSIENT OUTWARD K CURRENT
Ito is generated by a pore-forming α-subunit with six transmembrane segments (S1–S6). Accessory β-subunits can associate with this α-subunit (Figure 2A,
FIGURE 2

Structure and function of K channels.(A) Structure of voltage-gated K channel α-sunbunit (Kv) with six transmembrane segments (S1–S6). The S5–S6 segments face each other to form the central pore. The P-loop between the S5 and S6 segments acts as an ion conductance pathway and its signature motif G(Y/F)G functions as a K ion selectivity filter. Segment S4 senses voltage and moves outward during cell membrane depolarization resulting in conformational changes which open the pore. (B) There are two current components of Ito generated that can be distinguished according to their inactivation kinetics. Ito,fast inactivates with time constants (τ) of less than 100 ms, whereas the Ito,slow inactivates with τ of about 200 ms. (C) CaMKII can bind to Kv4.3 and phosphorylate serine 550 of its C terminus, which leads to altered current kinetics. SAP97 can also bind to Kv4.3 [at its Ser-Ala-Leu (SAL) segment] and possibly mediates the CaMKII-Kv4.3 interaction. (D) Inward rectifying potassium channels are formed by four α-subunits containing only two transmembrane segments (M1–M2) with a central P-loop as ion conductance pathway.
In human, rat, and canine tissue, Ito is generated mostly by the rapidly recovering channel population Kv4.3 (KCND3,
Despite this important role of Kv4.3 for Ito in human cardiac tissue, many animals species show a rather heterogeneous channel population comprised of Kv4.3, Kv1.4 (KCNA4), Kv4.2 (KCND2), and accessory KChIP subunits. In these species, Ito can be separated into the fast and slow component with varying relative contributions to total Ito. In rabbit and mouse cardiac myocytes, for instance, Kv1.4 has been shown to be responsible for the slow component while a complex of Kv4.2, Kv4.3, and KChIPs is responsible for the fast component (
The differential regulation in the expression and function of the various channel isoforms underlying Ito suggests that the two components Ito,fast and Ito,slow are functionally and structurally independent ion currents.
CaMKII-DEPENDENT REGULATION OF Ito EXPRESSION
CaMKII has been shown to influence the expression of channel isoforms underlying Ito. In mice overexpressing CaMKIIδ, it was shown that total Ito density is significantly reduced (
More evidence that the downregulation of Kv4 in HF after CaMKII overexpression may be secondary and not directly mediated by CaMKII is derived from experiments investigating the interaction of the MAGUK (membrane-associated guanylate kinase) protein SAP97 with Kv4.
In neurons, the interaction of the C-terminal Ser-Ala-Leu (SAL)-sequence of Kv4.2 with SAP97 has been shown to be crucial for trafficking of Kv4.2 to the synaptic membrane (
CaMKII-DEPENDENT REGULATION OF Ito GATING
The first evidence for a CaMKII-dependent regulation of cardiac potassium channel gating came from a study investigating human atrial myocytes (
Interestingly, this CaMKII-dependent enhancement of Ito may also be important for reactive oxygen-species (ROS) induced arrhythmogenesis. ROS are known to oxidize and activate CaMKII (
Thus, CaMKIIδc appears to regulate both channel expression and/or trafficking, but also acutely regulates channel gating properties. In both cases, acute regulation results in an enhancement of Ito. In contrast to this, chronic CaMKII overexpression that leads to HF development results in a reduction of Ito but this appears to be a secondary effect.
Kv4.3 AS AN IMPORTANT REGULATOR OF CaMKII ACTIVITY
While Kv4.3 is an important target for CaMKII, it may also influence CaMKII localization and activity. Recently, in HEK-293 cells transfected with Kv4.3 and His-tagged CaMKII, it was shown that Kv4.3 binds to CaM-dissociated CaMKII competitively at its CaM binding site (residues 301 and 307;
Since the CaMKII inhibitor KN93 also binds CaMKII at the CaM binding site (
This suggests that Kv4.3 may function as a reservoir for inactive CaMKII-units and exert an influence on CaMKII activation levels (Figure 2C). In accordance with this hypothesis, in vivo overexpression of Kv4.3 in mouse ventricular myocardium via multiple-site virus injection decreased the level of phosphorylated CaMKII, while CaMKII expression was not affected. CaMKII bound to Kv4.3 was also shown to be protected from activation by systolic Ca transients (
As previously mentioned, Kv4.3 is downregulated in HF (
INWARDLY RECTIFYING CURRENT IK1
In contrast to the voltage-gated K channels, inwardly rectifying potassium channels [Kir2.1 (KCNJ2), Kir2.2 (KCNJ12), Kir2.3 (KCNJ4), and Kir2.4 (KCNJ14)] are formed by four α-subunits containing only two transmembrane segments (M1–M2) with a central P-loop but without a voltage-sensor (Figure 2D;
This peculiar inward rectifying property of the Kir2.x channels that generate IK1 renders these channels important stabilizers of the resting membrane potential by neutralizing resting influx of positive ions (
In sinoatrial myocytes, the expression of channels forming IK1 is notably reduced, which allows for an unstable resting membrane potential that can be depolarized by If, thus inducing diastolic depolarization (
There is evidence that Kir2.x isoforms can assemble as homo- or heterotetrameres (
Ca OR CaMKII-DEPENDENT REGULATION OF IK1
IK1 functional expression also seems to be regulated differently under pathophysiological conditions. It was shown that IK1 density is reduced in failing rat ventricular myocytes (
Aside from the species, it could also be relevant if the studied model results in HF. It was shown that SAP97 co-immunoprecipitates with Kir2.2 in rat hearts (
Table 1
| Species | Model | IK1Current | Phenotype | Reference |
|---|---|---|---|---|
| Rat ventricular myocytes | Myocardial infarction | ↓ | ||
| Canine ventricular myocytes | High intracellular calcium | ↑ | ||
| Rabbit ventricular myocytes | Adenoviral CaMKII overexpression | ↑ | ||
| Mouse ventricular myocytes | Transgenic CaMKII overexpression | ↓ | Polymorphic and monomorphic VTs | |
| Mouse ventricular myocytes | Transgenic CaMKII inhibition (AC3-I expression) | ↑ | ||
| Mouse ventricular myocytes | Acute CaMKII inhibition by AC3-I dialysis | → | ||
| Mouse ventricular myocytes | Kir2.1 knock-down | ↓ | Less ventricular arrhythmias | |
| Mouse ventricular myocytes | Kir2.1 overexpression | ↑ | More ventricular arrhythmias | |
| Kir2.1-overexpressing [ESC]-derived myocytes | Transplantation of ESC-derived myocytes into mouse ventricles after MI | ↑ | Less spontaneous VTs, less inducible VTs | |
| Rabbit ventricular myocytes | Tachycardia-induced HF | |||
| Mouse ventricular myocytes | Calsequestrin-overexpression-induced HF | ↓ | QRS and QTc prolongation | |
| Mouse ventricular myocytes | Gαq-overexpression-induced hypertrophy | ↓ | ||
| Mouse ventricular myocytes | Calcineurin overexpression | → | ||
| Mouse ventricular myocytes | Dominant-negative Kv4.2 expression - induced HF | ↓ | ||
| Mouse ventricular myocytes | Dominant-negative Kv4.2 expression | ↓ | QRS and QTc prolongation | |
| Mouse ventricular myocytes | Kir2.1 overexpression | ↑ | More inducible, more stable VTs | |
| Mouse ventricular myocytes | Kir2.1 overexpression | ↑ | Bradycardia, AF, AV-Block, PVC, short QT | |
| Guinea pig ventricular myocytes | Kir2.1 overexpression | ↑ | QTc shortening | |
| Guinea pig ventricular myocytes | Dominant-negative Kir2.1 expression (downregulation) | ↓ | QTc prolongation | |
| Human ventricular myocytes | Dilated or ischemic cardiomyopathy | ↓ | APD prolongation | |
| Canine ventricular myocytes | Tachycardia-induced HF | ↓ | APD prolongation, QTc prolongation, more VTs | |
| Monolayers of cultured neo-natal rat ventricular myocytes | Homogeneous Kir2.1 overexpression | ↑ | No reentry arrhythmias inducible | |
| Monolayers of cultured neo-natal rat ventricular myocytes | Heterogeneous Kir2.1 overexpression | ↑ | Inducible reentry arrhythmias | |
| Monolayers of cultured neo-natal rat ventricular myocytes | Homogeneous Kir2.1 suppression | ↓ | No reentry arrhythmias inducible | |
| Monolayers of cultured neo-natal rat ventricular myocytes | Heterogeneous Kir2.1 suppression | ↓ | Inducible reentry arrhythmias | |
| Canine atrial myocytes | Tachycardia-induced HF | → | Inducible atrial fibrillation (AF) |
Synopsis of studies investigating IK1 and arrhythmias.
IK1 AND ARRHYTHMIAS
IK1 is generally regarded as anti-arrhythmic by stabilizing resting membrane potential. In a canine model of tachycardia-induced HF, reduced IK1 has been shown to increase the propensity for sudden cardiac death and ventricular tachycardia (
On the other hand, contrasting results have been shown for wild-type Kir2.1 overexpressing mice that have an increased propensity for ventricular arrhythmias (
This discrepancy may be solved by the fact that both increase or decrease of IK1 can be pro-arrhythmic if there is a substantial spatial heterogeneity in the functional expression profile (
DELAYED RECTIFYING K CHANNELS
The three channels Kv1.5 (KCNA5), hERG (KCNH2), and Kv7.1(KCNQ1) comprise the group of the delayed rectifying K channels. They generate IKur (ultra rapid), IKr (rapid), and IKs (slow), respectively. Together, they are important currents for phase 3 repolarization.
IKur is only present in atrial myocardium. In chronic human AF, it was shown that AP duration is reduced, possibly contributing to the arrhythmogenic mechanisms (
Since SAP97 and CaMKII have been shown to interact (
Besides IKur, other K currents may also be involved in AF. IK1, for instance, has been shown to be upregulated in AF possibly contributing to shortening of AP duration (
IKs is comprised of the pore-forming α-subunit Kv7.1, but also the auxiliary β-subunit KCNE1 (
Interestingly, co-immunoprecipitation experiments in yeast cells expressing wild-type Kv7.1 or mutated Kv7.1 with truncated α-helices showed that calmodulin can bind to the C-terminus of Kv7.1 (
Moreover, agarose-pulldown assays in HEK-293 cells revealed that LQTS-associated Kv7.1 mutants W392R, S373P, and A371T bound significantly less calmodulin than wild-type Kv7.1 (
In addition, the CaM- Kv7.1 interaction may also be relevant for the regulation of IKs gating. Patch-clamp experiments of inside-out membrane from Xenopus oocytes showed that application of calmodulin antagonist W7 significantly reduced current density of Kv7.1/KCNE1, while an increase in Ca significantly shifted voltage-dependence of channel activation toward more hyperpolarized membrane potentials (
Thus, the interaction of calmodulin and Kv7.1 appears to be critical for expression and function of IKs, with the intriguing possibility that regulatory mechanisms could also involve some form of CaMKII interaction with calmodulin and Kv7.1 or KCNE1.
ATP-SENSITIVE POTASSIUM CURRENT KATP
The ATP-sensitive potassium current KATP, comprising of Kir6.1 (KCNJ8) and Kir6.2 (KCNJ11) α-subunits, plays an important role in ischemic preconditioning (
The significance of KATP in HF and arrhythmogenesis is still largely unknown. There is evidence suggesting that KATP-channel opening with cromakalim produces more stable ventricular arrhythmias (
On the other hand, KATP-blockade with glibenclamide in non-failing canine hearts with induced VF delayed the termination of VF (
SUMMARY
While there is increasing evidence for an involvement of CaMKII in the regulation of K channels, many discrepancies are not yet understood. These discrepancies result from the great variability in the expression profile of K channels in different species and disease models. The greatest evidence so far exists for CaMKII-dependent regulation of Kv4.x expression, trafficking and function. Most intriguingly, the Kv4.x macromolecular complex appears to serve as a hotspot and reservoir for CaMKII, which may have profound impact on the regulation of various other CaMKII targets like Ca channels. CaMKII expression and activity has been shown to be increased in many animal models of HF, but also in human HF. Increased CaMKII activity has been shown to induce contractile dysfunction and arrhythmias. Therefore, a more detailed understanding of the mechanisms of K channel regulation by CaMKII is warranted.
Statements
Acknowledgments
Stefan Wagner and Lars S. Maier are funded by Deutsche Forschungsgemeinschaft (DFG) through an International Research Training Group GRK 1816. Lars S. Maier is funded by DFG grant MA 1982/4-2 and TPA03 SFB 1002. Lars S. Maier is also funded by the Fondation Leducq Transatlantic Network on “Redox and Nitrosative Regulation of Cardiac Remodeling.” Lars S. Maier, and Stefan Wagner, are funded by the DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung – German Centre for Cardiovascular Research). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Göttingen University.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
REFERENCES
1
AiX.CurranJ. W.ShannonT. R.BersD. M.PogwizdS. M. (2005). Ca2+/calmodulin–dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.Circ. Res.971314–1322. 10.1161/01.RES.0000194329.41863.89
2
AntzelevitchC.FishJ. (2001). Electrical heterogeneity within the ventricular wall.Basic Res. Cardiol.96517–527. 10.1007/s003950170002
3
BacksJ.BacksT.NeefS.KreusserM. M.LehmannL. H.PatrickD. M.et al (2009). The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.Proc. Natl. Acad. Sci. U.S.A.1062342–2347. 10.1073/pnas.0813013106
4
BarryD. M.XuH.SchuesslerR. B.NerbonneJ. M. (1998). Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 subunit.Circ. Res.83560–567. 10.1161/01.RES.83.5.560
5
BersD. M. (2002a). Cardiac excitation-contraction coupling.Nature415198–205. 10.1038/415198a
6
BersD. M. (2002b). Excitation-Contraction Coupling and Cardiac Contractile Forceed. BersD. M. (Boston, MA:Kluwer Academic Publishers) 39–62.
7
BeuckelmannD. J.NabauerM.ErdmannE. (1993). Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure.Circ. Res.73379–385. 10.1161/01.RES.73.2.379
8
BrahmajothiM. V.CampbellD. L.RasmussonR. L.MoralesM. J.TrimmerJ. S.NerbonneJ. M.et al (1999). Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes.J. Gen. Physiol.113581–600. 10.1085/jgp.113.4.581
9
BrenyoA. J.HuangD. T.AktasM. K. (2012). Congenital long and short QT syndromes.Cardiology122237–247. 10.1159/000339537
10
CaiB.GiridharanS. S. P.ZhangJ.SaxenaS.BahlK.SchmidtJ. A.et al (2013). Differential roles of C-terminal Eps15 homology domain proteins as vesiculators and tubulators of recycling endosomes.J. Biol. Chem.28830172–30180. 10.1074/jbc.M113.488627
11
ChenY.-H.XuS.-J.BendahhouS.WangX.-L.WangY.XuW.-Y.et al (2003). KCNQ1 gain-of-function mutation in familial atrial fibrillation.Science299251–254. 10.1126/science.1077771
12
ChoH.-S.TakanoM.NomaA. (2003). The electrophysiological properties of spontaneously beating pacemaker cells isolated from mouse sinoatrial node.J.~Physiol.550169–180. 10.1113/jphysiol.2003.040501
13
ColinasO. (2006). Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes.Am. J. Physiol. Heart Circ. Physiol. 291H1978–H1987. 10.1152/ajpheart.01373.2005
14
CuiY. Y.LiangP.WangK. W. (2008). Enhanced trafficking of tetrameric Kv4.3 channels by KChIP1 clamping.Neurochem. Res.332078–2084. 10.1007/s11064-008-9688-7
15
DhamoonA. S. (2004). Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K+ current.Circ. Res. 941332–1339. 10.1161/01.RES.0000128408.66946.67
16
DhamoonA. S.JalifeJ. (2005). The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis.Heart Rhythm2316–324. 10.1016/j.hrthm.2004.11.012
17
DixonJ. E.ShiW.WangH.-S.McDonaldC.YuH.WymoreR. S.et al (1996). Role of the Kv4.3 K+ channel in ventricular muscle: a molecular correlate for the transient outward current.Circ. Res. 79659–668. 10.1161/01.RES.79.4.659
18
DobrevD.RavensU. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation.Basic Res. Cardiol.98137–148. 10.1007/s00395-003-0409-8
19
EldstromJ.ChoiW. S.SteeleD. F.FedidaD. (2003). SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism.FEBS Lett. 547205–211 . 10.1016/S0014-5793(03)00668-9
20
El-HaouS.BalseE.NeyroudN.DilanianG.GavilletB.AbrielH.et al (2009). Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes.Circ. Res.104758–769. 10.1161/CIRCRESAHA.108.191007
21
EricksonJ. R.JoinerM. A.GuanX.KutschkeW.YangJ.OddisC. V.et al (2008). A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.Cell133462–474. 10.1016/j.cell.2008.02.048
22
EricksonJ. R.PereiraL.WangL.HanG.FergusonA.DaoK.et al (2013). Diabetic hyperglycemia activates CaMKII and arrhythmias by O-linked glycosylation.Nature502372–376. 10.1038/nature12537
23
FauconnierJ.LacampagneA.RauzierJ.VassortG.RichardS. (2005). Ca-dependent reduction of I in rat ventricular cells: a novel paradigm for arrhythmia in heart failure?Cardiovasc. Res.68204–212. 10.1016/j.cardiores.2005.05.024
24
FedidaD.WibleB.WangZ.FerminiB.FaustF.NattelS.et al (1993). Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current.Circ. Res.73210–216. 10.1161/01.RES.73.1.210
25
GaboritN.Le BouterS.SzutsV.VarroA.EscandeD.NattelS.et al (2007). Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.J. Physiol.582675–693. 10.1113/jphysiol.2006.126714
26
GardoniF.MauceriD.MarcelloE.SalaC.Di LucaM.JerominA. (2007). SAP97 directs the localization of Kv4.2 to spines in hippocampal neurons: regulation by CaMKII. J. Biol. Chem. 28228691–28699. 10.1074/jbc.M701899200
27
GoA. S.MozaffarianD.RogerV. L.BenjaminE. J.BerryJ. D.BordenW. B.et al (2012). Heart disease and stroke statistics–2013 update: a report from the american heart association.Circulation127e6–e245. 10.1161/CIR.0b013e31828124ad
28
GodreauD.VranckxR.MaguyA.Rücker-MartinC.GoyenvalleC.AbdelshafyS.et al (2002). Expression, regulation and role of the MAGUK protein SAP-97 in human atrial myocardium.Cardiovasc. Res.56433–442. 10.1016/S0008-6363(02)00602-8
29
GrandiE.PuglisiJ. L.WagnerS.MaierL. S.SeveriS.BersD. M. (2007). Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte Ion currents and action potentials.Biophys. J.933835–3847. 10.1529/biophysj.107.114868
30
HasenfussG. (1998). Alterations of calcium-regulatory proteins in heart failure.Cardiovasc. Res.37279–289. 10.1016/S0008-6363(97)00277-0
31
HibinoH.InanobeA.FurutaniK.MurakamiS.FindlayI.KurachiY. (2010). Inwardly rectifying potassium channels: their structure, function, and physiological roles.Physiol. Rev.90291–366. 10.1152/physrev.00021.2009
32
HochB.MeyerR.HetzerR.KrauseE.-G.KarczewskiP. (1999). Identification and expression of -isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium.Circ. Res.84713–721. 10.1161/01.RES.84.6.713
33
HuS. S.KongL. Z.GaoR. L.ZhuM. L.WangW.WangY. J.et al (2012). Outline of the report on cardiovascular disease in China, 2010.Biomed. Environ. Sci.25251–256.
34
JostN.ViragL.ComtoisP.OrdögB.SzutsV.SeprenyiG.et al (2013). Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs.J. Physiol.5914189–4206. 10.1113/jphysiol.2013.261198
35
KaabS.DixonJ.DucJ.AshenD.NabauerM.BeuckelmannD. J.et al (1998). Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density.Circulation 981383–1393. 10.1161/01.CIR.98.14.1383
36
KääbS.NussH. B.ChiamvimonvatN.O’RourkeB.PakP. H.KassD. A.et al (1996). Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure.Circ. Res.78262–273. 10.1161/01.RES.78.2.262
37
KarleC. A. (2002). Human cardiac inwardly-rectifying K+ channel Kir2.1b is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system.Circulation 1061493–1499. 10.1161/01.CIR.0000029747.53262.5C
38
KeskanokwongT.LimH. J.ZhangP.ChengJ.XuL.LaiD.,et al (2010). Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation.Eur. Heart J. 32305–315. 10.1093/eurheartj/ehq469
39
KirchheferU.SchmitzW.ScholzH.NeumannJ. (1999). Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts.Cardiovasc. Res.42254–261. 10.1016/S0008-6363(98)00296-X
40
KlineC. F.WrightP. J.KovalO. M.ZmudaE. J.JohnsonB. L.AndersonM. E.et al (2013). IV-Spectrin and CaMKII facilitate Kir6.2 regulation in pancreatic beta cells.Proc. Natl. Acad. Sci. U.S.A. 11017576–17581. 10.1073/pnas.1314195110
41
KnollmannB. C.Knollmann-RitschelB. E.WeissmanN. J.JonesL. R.MoradM. (2000). Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin.J. Physiol.525483–498. 10.1111/j.1469-7793.2000.t01-1-00483.x
42
LeonoudakisD.ContiL. R.RadekeC. M.McGuireL. M. M.VandenbergC. A. (2004). A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels.J.~Biol. Chem.27919051–19063. 10.1074/jbc.M400284200
43
LiJ. (2004). Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability.Am. J. Physiol. Heart Circ. Physiol.287H2790–H2802. 10.1152/ajpheart.00114.2004
44
LiJ.MarionneauC.KovalO.ZingmanL.MohlerP. J.NerbonneJ. M.et al (2007). Calmodulin kinase II inhibition enhances ischemic preconditioning by augmenting ATP-sensitive K+ current.Channels1387–394.
45
LiJ.MarionneauC.ZhangR.ShahV.HellJ. W.NerbonneJ. M.et al (2006). Calmodulin kinase II Inhibition shortens action potential duration by upregulation of K+ currents.Circ. Res.991092–1099. 10.1161/01.RES.0000249369.71709.5c
46
LiY.KraniasE. G.MigneryG. A.BersD. M. (2002). Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.Circ. Res.90309–316. 10.1161/hh0302.105660
47
LiaoS.-Y.TseH.-F.ChanY.-C.Mei-Chu YipP.ZhangY.LiuY.et al (2013). Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction.Heart Rhythm10273–282. 10.1016/j.hrthm.2012.10.008
48
LingH.ZhangT.PereiraL.MeansC. K.ChengH.GuY.et al (2009). Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in mice.J. Clin. Invest.1191230–1240. 10.1172/JCI38022
49
LuoM.AndersonM. E. (2013). Mechanisms of altered Ca2+ handling in heart failure.Circ. Res.113690–708. 10.1161/CIRCRESAHA.113.301651
50
MaierL.BersD. (2007). Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation–contraction coupling in the heart.Cardiovasc. Res.73631–640. 10.1016/j.cardiores.2006.11.005
51
MaierL. S. (2003). Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release.Circ. Res.92904–911. 10.1161/01.RES.0000069685.20258.F1
52
MarionneauC.TownsendR. R.NerbonneJ. M. (2011). Proteomic analysis highlights the molecular complexities of native Kv4 channel macromolecular complexes.Semin. Cell Dev. Biol.22145–152. 10.1016/j.semcdb.2010.10.004
53
MatsudaHCruzJ. D. S. (1993). Voltage-dependent block by internal Ca2+ ions of inwardly rectifying K+ channels in guinea-pig ventricular cells.J. Physiol.470295–311.
54
MatsudaH.SaigusaA.IrisawaH. (1987). Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+.Nature325156–159. 10.1038/325156a0
55
McLerieM. (2003). Dominant-negative suppression of I(K1) in the mouse heart leads to altered cardiac excitability.J. Mol. Cell. Cardiol.35367–378. 10.1016/S0022-2828(03)00014-2
56
Medeiros-DomingoA.TanB.-H.,CrottiL.TesterD. J.EckhardtL.CuorettiA.et al (2010). Gain-of-function mutation S422L in the KCNJ8-encoded cardiac KATP channel Kir6.1 as a pathogenic substrate for J-wave syndromes.Heart Rhythm 71466–1471. 10.1016/j.hrthm.2010.06.016
57
MiakeJ.MarbánE.NussH. B. (2003). Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.J. Clin. Invest.1111529–1536. 10.1172/JCI200317959
58
MitaraiS. (2000). Changes in ionic currents and beta-adrenergic receptor signaling in hypertrophied myocytes overexpressing Gaq.Am. J. Physiol. Heart Circ. Physiol. H139–H148. 10.1016/S0008-6363(02)00403-0
59
MurataM.BuckettP. D.ZhouJ.BrunnerM.FolcoE.KorenG. (2001). SAP97 interacts with Kv1. 5 in heterologous expression systems.Am. J. Physiol. Heart Circ. Physiol.281H2575–H2584.
60
NagyN.AcsaiK.KormosA.SebõkZ.FarkasA. S.JostN.et al (2013). [Ca2+]i-induced augmentation of the inward rectifier potassium current (IK1) in canine and human ventricular myocardium.Pflügers Arch. Eur. J. Physiol.Available at: http://link.springer.com/10.1007/s00424-013-1309-x (accessed August 29, 2013).
61
NeefS.DybkovaN.SossallaS.OrtK. R.FluschnikN.NeumannK.et al (2010). CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation.Circ. Res.1061134–1144. 10.1161/CIRCRESAHA.109.203836
62
NerbonneJ. M. (2011). Repolarizing cardiac potassium channels: multiple sites and mechanisms for CaMKII-mediated regulation.Heart Rhythm8938–941. 10.1016/j.hrthm.2011.01.018
63
NeumannT.BiermannJ.NeumannA.WasemJ.ErtlG.DietzR.et al (2009). Herzinsuffizienz: Häufigster Grund für Krankenhausaufenthalte.Dtsch. Ärztebl.106269–275.
64
NicholsM.TownsendN.ScarboroughP.RaynerM. (2013). Cardiovascular disease in Europe: epidemiological update.Eur. Heart J.343028–3034. 10.1093/eurheartj/eht356
65
NiwaN.NerbonneJ. M. (2010). Molecular determinants of cardiac transient outward potassium current (Ito) expression and regulation.J. Mol. Cell. Cardiol.4812–25. 10.1016/j.yjmcc.2009.07.013
66
NoujaimS. F.PanditS. V.BerenfeldO.VikstromK.CerroneM.MironovS.et al (2006). Up-regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotors.J. Physiol.578315–326. 10.1113/jphysiol.2006.121475
67
PakP. H.NussH. B.TuninR. S.Kääb,S.TomaselliG. F.MarbanE.et al (1997). Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy.J. Am. Coll. Cardiol.30576–584. 10.1016/S0735-1097(97)00193-9
68
PanamaB. K.McLerieM.LopatinA. N. (2010). Functional consequences of Kir2.1/Kir2.2 subunit heteromerization.Pflügers Arch. Eur. J. Physiol.460839–849. 10.1007/s00424-010-0864-7
69
Petkova-KirovaP. S. (2006). Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha.Am. J. Physiol. Heart Circ. Physiol.290H2098–H2107. 10.1152/ajpheart.00097.2005
70
PetrashevskayaN. N.BodiI.RubioM.MolkentinJ. D.SchwartzA. (2002). Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse.Cardiovasc. Res.54117–132. 10.1016/S0008-6363(02)00241-9
71
PiaoL.LiJ.McLerieM.LopatinA. N. (2007). Transgenic upregulation of IK1 in the mouse heart is proarrhythmic.Basic Res. Cardiol.102416–428. 10.1007/s00395-007-0659-y
72
PieskeB.MaierL. S.PiacentinoV.WeisserJ.HasenfussG.HouserS. (2002). Rate Dependence of [Na+]i and contractility in nonfailing and failing human myocardium.Circulation106447–453. 10.1161/01.CIR.0000023042.50192.F4
73
PiolettiM.FindeisenF.HuraG. L.Minor.D. L. (2006). Three-dimensional structure of the KChIP1–Kv4.3 T1 complex reveals a cross-shaped octamer.Nat. Struct. Mol. Biol. 13987–995. 10.1038/nsmb1164
74
QuintanillaJ. G.MorenoJ.ArchondoT.ChinA.Pérez-CastellanoN.UsandizagaE.et al (2013). KATP channel opening accelerates and stabilizes rotors in a swine heart model of ventricular fibrillation.Cardiovasc. Res.99576–585. 10.1093/cvr/cvt093
75
ReganC. P.KissL.StumpG. L.McIntyreC. J.BeshoreD. C.LivertonN. J.et al (2007). Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failure.J. Pharmacol. Exp. Ther.324322–330. 10.1124/jpet.107.127654
76
RellosP.PikeA. C. W.NiesenF. H.SalahE.LeeW. H.Von DelftF.et al (2010). Structure of the CaMKII delta calmodulin complex reveals the molecular mechanism of CaMKII kinase activation.PLoS Biol. 8:e1000426. 10.1371/journal.pbio.1000426
77
RodenD. M. (2008). Long-QT Syndrome.N. Engl. J. Med.358169–176. 10.1056/NEJMcp0706513
78
RoeperJ. (1997).Frequency-dependent inactivation of mammalian A-type K channel KV1.4 regulated by Ca2/calmodulin- dependent protein kinase.J. Neurosci. 3379–3391.
79
RoseJ. (2005). Molecular correlates of altered expression of potassium currents in failing rabbit myocardium.Am. J. Physiol. Heart Circ. Physiol.288H2077–H2087. 10.1152/ajpheart.00526.2003
80
RuscicK. J.MiceliF.Villalba-GaleaC. A.DaiH.MishinaY.BezanillaF.et al (2013). PNAS Plus: IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits.Proc. Natl. Acad. Sci. U.S.A.110E559–E566. 10.1073/pnas.1222616110
81
SekarR. B.KizanaE.ChoH. C.MolitorisJ. M.HeskethG. G.EatonB. P.et al (2009). IK1 heterogeneity affects genesis and stability of spiral waves in cardiac myocyte monolayers.Circ. Res.104355–364. 10.1161/CIRCRESAHA.108.178335
82
SergeantG. P.(2005). Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II.Am. J. Physiol. Cell Physiol. 288C304–C313. 10.1152/ajpcell.00293.2004
83
ShamgarL. (2006). Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.Circ. Res.981055–1063. 10.1161/01.RES.0000218979.40770.69
84
ShryockJ. C.SongY.RajamaniS.AntzelevitchC.BelardinelliL. (2013). The arrhythmogenic consequences of increasing late INa in the cardiomyocyte.Cardiovasc. Res.Available at: cardiovascres.oxfordjournals.org/content/early/2013/07/01/cvr.cvt145.abstract (accessed December 12, 2013).
85
SnydersD. J. (1999). Structure and function of cardiac potassium channels.Cardiovasc. Res.42377–390. 10.1016/S0008-6363(99)00071-1
86
SplawskiI.Tristani-FirouziM.LehmannM. H.SanguinettiM. C.KeatingM. T. (1997). Mutations in the hminK gene cause long QT syndrome and suppress lKs function.Nat. Genet.17338–340. 10.1038/ng1197-338
87
Sumi. (1991). The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells.Biochem. Biophys. Res. Commun.181968–975. 10.1016/0006-291X(91)92031-E
88
SzutsV.MénesiD.Varga-OrvosZ.Zvaraá.HoushmandN.BitayM.et al (2013). Altered expression of genes for Kir ion channels in dilated cardiomyopathy1.Can. J. Physiol. Pharmacol.91648–656. 10.1139/cjpp-2012-0413
89
TaylorT. G.VenableP. W.ShibayamaJ.WarrenM.ZaitsevA. V. (2012). Role of KATP channel in electrical depression and asystole during long-duration ventricular fibrillation in ex vivo canine heart.Am. J. Physiol. Heart Circ. Physiol.302H2396–H2409. 10.1152/ajpheart.00752.2011
90
TessierS. (2001). Cumulative inactivation of the outward potassium current: a likely mechanism underlying electrical memory in human atrial myocytes.J. Mol. Cell. Cardiol.33755–767. 10.1006/jmcc.2001.1345
91
TessierS.KarczewskiP.KrauseE.-G.PansardY.AcarC.Lang-LazdunskiM.et al (1999). Regulation of the transient outward K+ current by Ca2+/calmodulin-dependent protein kinases II in human atrial myocytes.Circ. Res.85810–819. 10.1161/01.RES.85.9.810
92
TikkanenJ. T.AnttonenO.JunttilaM. J.AroA. L.KerolaT.RissanenH. A.et al (2009). Long-term outcome associated with early repolarization on electrocardiography.N. Engl. J. Med.3612529–2537. 10.1056/NEJMoa0907589
93
TsuboiM.AntzelevitchC. (2006). Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).Heart Rhythm3328–335. 10.1016/j.hrthm.2005.11.026
94
VargaA. W. (2004). Calcium-calmodulin-dependent kinase II modulates Kv4.2 channel expression and upregulates neuronal A-type potassium currents.J. Neurosci. 243643–3654. 10.1523/JNEUROSCI.0154-04.2004
95
WagnerS.DybkovaN.RasenackE. C.JacobshagenC.FabritzL.KirchhofP.et al (2006). Ca/Calmodulin-dependent protein kinase II regulates cardiac Na+ channels.J. Clin. Invest.1163127–3138. 10.1172/JCI26620
96
WagnerS.HackerE.GrandiE.WeberS. L.DybkovaN.SossallaS.et al (2009). Ca/calmodulin kinase II differentially modulates potassium currents.Circ. Arrhythm. Electrophysiol.2285–294. 10.1161/CIRCEP.108.842799
97
WagnerS.RuffH. M.WeberS. L.BellmannS.SowaT.SchulteT.et al (2011). Reactive oxygen species–activated Ca/calmodulin kinase IIδ is required for late INa augmentation leading to cellular Na and Ca overload.Circ. Res.108555–565. 10.1161/CIRCRESAHA.110.221911
98
WangY.ChengJ.TandanS.JiangM.McCloseyD. T.HillJ. A. (2006a). Transient-outward K+ channel inhibition facilitates L-type Ca2+ current in heart.J. Cardiovasc. Electrophysiol.17298–304. 10.1111/j.1540-8167.2006.00362.x
99
WangH.YanY.LiuQ.HuangY.ShenY.ChenL.et al (2006b). Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunits.Nat. Neurosci.1032–39. 10.1038/nn1822
100
WarrenM.GuhaP. K.BerenfeldO.ZaitsevA.AnumonwoJ. M. B.DhamoonA. S.et al (2003). Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart.J. Cardiovasc. Electrophysiol.14621–631. 10.1046/j.1540-8167.2003.03006.x
101
WeissJ. N.GarfinkelA.KaragueuzianH. S.ChenP.-S.QuZ. (2010). Early afterdepolarizations and cardiac arrhythmias.Heart Rhythm71891–1899. 10.1016/j.hrthm.2010.09.017
102
WettwerE. (2004). Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation.Circulation1102299–2306. 10.1161/01.CIR.0000145155.60288.71
103
WickendenA. D.LeeP.SahR.HuangQ.FishmanG. I.BackxP. H. (1999). Targeted expression of a dominant-negative Kv4.2 K+ channel subunit in the mouse heart.Circ. Res.851067–1076. 10.1161/01.RES.85.11.1067
104
XuH.GuoW.NerbonneJ. M. (1999). Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes.J.~Gen. Physiol.113661–678. 10.1085/jgp.113.5.661
105
YanG.-X.AntzelevitchC. (1996). Cellular basis for the electrocardiographic J wave.Circulation93372–379. 10.1161/01.CIR.93.2.372
106
ZhangR.KhooM. S. C.WuY.YangY.GrueterC. E.NiG.et al (2005). Calmodulin kinase II inhibition protects against structural heart disease.Nat. Med.11409–417. 10.1038/nm1215
107
ZhangX.SzetoC.GaoE.TangM.JinJ.FuQ.et al (2012). Cardiotoxic and cardioprotective features of chronic -adrenergic signaling.Circ. Res.112498–509. 10.1161/CIRCRESAHA.112.273896
108
ZhaoZ.XieY.WenH.XiaoD.AllenC.FefelovaN.et al (2012). Role of the transient outward potassium current in the genesis of early afterdepolarizations in cardiac cells.Cardiovasc. Res.95308–316. 10.1093/cvr/cvs183
109
ZichaS.XiaoL.StaffordS.ChaT. J.HanW.VarroA.et al (2004). Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts.J. Physiol.561735–748. 10.1113/jphysiol.2004.075861
110
ZobelC.ChoH. C.NguyenT.-T.PekhletskiR.DiazR. J.WilsonG. J.et al (2003). Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2.J. Physiol.550365–372. 10.1113/jphysiol.2002.036400
Summary
Keywords
CaMKII, K channel, heart failure, action potential, arrhythmias
Citation
Mustroph J, Maier LS and Wagner S (2014) CaMKII regulation of cardiac K channels. Front. Pharmacol. 5:20. doi: 10.3389/fphar.2014.00020
Received
13 December 2013
Accepted
31 January 2014
Published
21 February 2014
Volume
5 - 2014
Edited by
Eleonora Grandi, University of California at Davis, USA
Reviewed by
Stephane Hatem, Pierre-and-Marie-Curie University, France; Daniel C. Bartos, University of California at Davis, USA
Copyright
© 2014 Mustroph, Maier and Wagner.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Stefan Wagner, Department of Cardiology, University Medical Center Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany e-mail: swagner@med.uni-goettingen.de
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.